文献速递神经MR

动脉自旋标记与DSC灌注指标提高神经放射科医师对治疗后高级别胶质瘤监测MR影像临床判读的一致性——本机构经验

Arterial Spin-Labeling and DSC Perfusion Metrics Improve Agreement in Neuroradiologists' Clinical Interpretations of Posttreatment High-Grade Glioma Surveillance MR Imaging-An Institutional Experience.
PubMed 文献 · AJNR Am J Neuroradiol · 2024-04-08

本回顾性研究纳入45例治疗后高级别胶质瘤成人患者,4名神经放射科医师分别基于增强MR及追加动脉自旋标记-CBF、DSC-相对CBV、DSC-肿瘤分数负荷后赋予BT-RADS评分。追加灌注指标提高了评分者间一致性、与多学科共识组的一致性及信心评分,其中DSC-肿瘤分数负荷表现最佳,并使2%–20%患者的判读发生具临床意义的变化。

要点

  • 追加DSC-肿瘤分数负荷后评分者间一致性最高(κ=0.70),与共识组一致性亦最高(κ=0.66–0.80)。
  • 单独增强MR评分者间一致性为中等(κ=0.63),追加灌注指标后一致性均有所提高。
  • 追加灌注后2%–20%患者的判读发生具临床意义的变化,可能改变治疗管理。

核心结论

  • 在增强MR基础上追加灌注指标可提高治疗后高级别胶质瘤判读的评分者间一致性、与共识组一致性及评分者信心,其中DSC-肿瘤分数负荷的一致性及信心评分最高,并可使高达20%患者的判读发生可能改变治疗管理的变化。

研究设计与样本

  • 回顾性研究,纳入45例接受治疗后灌注MR成像的高级别胶质瘤成人患者,由4名神经放射科医师基于增强MR及追加动脉自旋标记-CBF、DSC-相对CBV、DSC-肿瘤分数负荷后分别赋予脑肿瘤报告与数据系统评分,采用κ统计评估一致性,采用5点Likert量表评估信心评分。

诊断标准与关键数值

  • 评分者间一致性:单独增强MR κ=0.63;追加动脉自旋标记-CBF κ=0.67;追加DSC-相对CBV κ=0.66;追加DSC-肿瘤分数负荷 κ=0.70。与多学科共识组一致性在追加DSC-肿瘤分数负荷时最高(κ=0.66–0.80)。

临床应用与阅片要点

  • 日常阅片与报告中对治疗后高级别胶质瘤监测MR,可在增强MR基础上追加动脉自旋标记-CBF、DSC-相对CBV及DSC-肿瘤分数负荷,其中DSC-肿瘤分数负荷与共识组一致性及信心评分最高;追加灌注后2%–20%患者的判读发生具临床意义的变化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: MR perfusion has shown value in the evaluation of posttreatment high-grade gliomas, but few studies have shown its impact on the consistency and confidence of neuroradiologists' interpretation in routine clinical practice. We evaluated the impact of adding MR perfusion metrics to conventional contrast-enhanced MR imaging in posttreatment high-grade glioma surveillance imaging.

MATERIALS AND METHODS: This retrospective study included 45 adults with high-grade gliomas who had posttreatment perfusion MR imaging. Four neuroradiologists assigned Brain Tumor Reporting and Data System scores for each examination on the basis of the interpretation of contrast-enhanced MR imaging and then after the addition of arterial spin-labeling-CBF, DSC-relative CBV, and DSC-fractional tumor burden. Interrater agreement and rater agreement with a multidisciplinary consensus group were assessed with κ statistics. Raters used a 5-point Likert scale to report confidence scores. The frequency of clinically meaningful score changes resulting from the addition of each perfusion metric was determined.

RESULTS: Interrater agreement was moderate for contrast-enhanced MR imaging alone (κ = 0.63) and higher with perfusion metrics (arterial spin-labeling-CBF, κ = 0.67; DSC-relative CBV, κ = 0.66; DSC-fractional tumor burden, κ = 0.70). Agreement between raters and consensus was highest with DSC-fractional tumor burden (κ = 0.66-0.80). Confidence scores were highest with DSC-fractional tumor burden. Across all raters, the addition of perfusion resulted in clinically meaningful interpretation changes in 2%-20% of patients compared with contrast-enhanced MR imaging alone.

CONCLUSIONS: Adding perfusion to contrast-enhanced MR imaging improved interrater agreement, rater agreement with consensus, and rater confidence in the interpretation of posttreatment high-grade glioma MR imaging, with the highest agreement and confidence scores seen with DSC-fractional tumor burden. Perfusion MR imaging also resulted in interpretation changes that could change therapeutic management in up to 20% of patients.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Yamin G, Tranvinh E, Lanzman BA, et al. Arterial Spin-Labeling and DSC Perfusion Metrics Improve Agreement in Neuroradiologists' Clinical Interpretations of Posttreatment High-Grade Glioma Surveillance MR Imaging-An Institutional Experience. AJNR Am J Neuroradiol. 2024. PMID: 38453410. doi:10.3174/ajnr.A8190

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。